Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Prevention | 21 |
| Treatment | 16 |
| Supportive Care | 7 |
| Diagnostic | 5 |
| Screening | 3 |
| Basic Science | 2 |
| Other | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 101 |
| interventional | 55 |
| Observational | 41 |
| Registry | 5 |
```
| intervention_type | Study_Count |
|---|---|
| Drug | 15 |
| Drug|placebo | 11 |
| Other | 9 |
| Diagnostic Test | 4 |
| Drug|Procedure | 3 |
| Biological|Drug|Radiation | 2 |
| Behavioral|Other | 1 |
| Biological|Drug|Genetic|Other|Procedure | 1 |
| Biological|Drug|Other | 1 |
| Biological|Procedure | 1 |
| Device | 1 |
| Device|Other|Procedure | 1 |
| Drug|Other | 1 |
| Drug|Radiation | 1 |
| Other|Procedure | 1 |
| placebo|Procedure | 1 |
| Procedure | 1 |
| Country | Study_Count |
|---|---|
| United States | 19 |
| Brazil | 3 |
| Canada | 3 |
| Italy | 3 |
| China | 2 |
| Denmark | 2 |
| Spain | 2 |
| United Kingdom | 2 |
| United States|Canada|Switzerland | 2 |
| Austria | 1 |
| Egypt | 1 |
| France | 1 |
| Germany | 1 |
| Greece | 1 |
| Hong Kong | 1 |
| Japan | 1 |
| Korea, Republic of | 1 |
| Lithuania | 1 |
| NA | 1 |
| Netherlands | 1 |
| Switzerland | 1 |
| Tanzania | 1 |
| Turkey | 1 |
| United States|Australia|Canada | 1 |
| United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland | 1 |
| United States|Puerto Rico|Saudi Arabia | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 36 |
| 2 | 8 |
| 4 | 2 |
| 10 | 1 |
| 14 | 1 |
| 19 | 1 |
| 39 | 1 |
| 61 | 1 |
| 63 | 1 |
| 148 | 1 |
| 174 | 1 |
| 559 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 23 |
| Phase 3 | 13 |
| Phase 2 | 9 |
| Phase 1 | 4 |
| Phase 4 | 3 |
| Early Phase 1 | 1 |
| Phase 1/Phase 2 | 1 |
| Phase 2/Phase 3 | 1 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 10 |
| 2 | 31 |
| 3 | 6 |
| 4 | 3 |
| 8 | 1 |
| NA | 4 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 20 | 5.0000 | 3.0 | 70 | 34.0000 | 144 | 13.0000 | 90 |
| 1st Qu. | 20 | 59.0000 | 12.0 | 70 | 94.0000 | 144 | 200.0000 | 102 |
| Median | 20 | 128.0000 | 31.5 | 70 | 122.0000 | 144 | 253.0000 | 114 |
| Mean | 20 | 154.2609 | 44.0 | 70 | 190.2222 | 144 | 311.7692 | 118 |
| 3rd Qu. | 20 | 195.0000 | 63.5 | 70 | 300.0000 | 144 | 398.0000 | 132 |
| Max. | 20 | 597.0000 | 110.0 | 70 | 468.0000 | 144 | 817.0000 | 150 |
| group_type | Group_Count |
|---|---|
| Experimental | 57 |
| Active Comparator | 20 |
| Placebo Comparator | 12 |
| No Intervention | 11 |
| Other | 10 |
| NA | 4 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 35 |
| Single Group Assignment | 19 |
| Crossover Assignment | 1 |
| primary_purpose | Study_Count |
|---|---|
| Prevention | 21 |
| Treatment | 16 |
| Supportive Care | 7 |
| Diagnostic | 5 |
| Screening | 3 |
| Basic Science | 2 |
| Other | 1 |
| Country | Study_Count |
|---|---|
| United States | 16 |
| France | 5 |
| Canada | 2 |
| Italy | 2 |
| Korea, Republic of | 2 |
| Netherlands | 2 |
| United States|Canada | 2 |
| Australia | 1 |
| China | 1 |
| Denmark | 1 |
| Denmark|Finland|Iceland|Ireland|Netherlands|Norway|Sweden | 1 |
| Egypt | 1 |
| Germany | 1 |
| Ireland | 1 |
| Poland | 1 |
| Russian Federation | 1 |
| Slovenia | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 27 |
| 2 | 5 |
| 3 | 2 |
| 4 | 1 |
| 6 | 1 |
| 13 | 1 |
| 14 | 1 |
| 15 | 1 |
| 20 | 1 |
| 105 | 1 |
| Measure | Observational |
|---|---|
| Min | 12.0000 |
| 1st Qu | 45.0000 |
| Median | 128.0000 |
| Mean | 920.7317 |
| 3rd Qu | 220.0000 |
| Max | 20000.0000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 26 |
| Case-Only | 8 |
| Case-Control | 4 |
| Case-Crossover | 1 |
| Other | 1 |
| NA | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 35 |
| Retrospective | 4 |
| Cross-Sectional | 1 |
| NA | 1 |
| Country | Study_Count |
|---|---|
| United States | 2 |
| China | 1 |
| Israel | 1 |
| Spain | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 4 |
| 2 | 1 |
| Measure | Registries |
|---|---|
| Min | 55 |
| 1st Qu | 65 |
| Median | 110 |
| Mean | 272 |
| 3rd Qu | 130 |
| Max | 1000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 4 |
| Other | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 5 |
| target_duration | Study_Count |
|---|---|
| 1 Year | 2 |
| 2 Years | 1 |
| 5 Years | 1 |
| 6 Months | 1 |
#If less then 500 trials
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03862131 | PROactive Evaluation of Function to Avoid CardioToxicity | https://ClinicalTrials.gov/show/NCT03862131 | Recruiting | Washington University School of Medicine | 2022-12-31 |
| NCT04092309 | Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation | https://ClinicalTrials.gov/show/NCT04092309 | Recruiting | University of Athens | 2020-09-01 |
| NCT03418961 | S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer | https://ClinicalTrials.gov/show/NCT03418961 | Recruiting | Southwest Oncology Group | 2023-02-01 |
| NCT03186404 | Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study | https://ClinicalTrials.gov/show/NCT03186404 | Recruiting | University Health Network, Toronto | 2020-12-31 |
| NCT03166813 | Remote Ischaemic Preconditioning in Childhood Cancer | https://ClinicalTrials.gov/show/NCT03166813 | Recruiting | The University of Hong Kong | 2020-09-30 |
| NCT02943590 | STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) | https://ClinicalTrials.gov/show/NCT02943590 | Recruiting | Massachusetts General Hospital | 2021-06-30 |
| NCT02942615 | The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy. | https://ClinicalTrials.gov/show/NCT02942615 | Recruiting | Ruijin Hospital | 2019-12-31 |
| NCT02909712 | Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania | https://ClinicalTrials.gov/show/NCT02909712 | Active, not recruiting | London School of Hygiene and Tropical Medicine | 2020-01-31 |
| NCT02796365 | Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy | https://ClinicalTrials.gov/show/NCT02796365 | Completed | Henry Ford Health System | 2018-12-31 |
| NCT02666378 | Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | https://ClinicalTrials.gov/show/NCT02666378 | Recruiting | Dana-Farber Cancer Institute | 2020-12-31 |
| NCT02652975 | Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium | https://ClinicalTrials.gov/show/NCT02652975 | Completed | University of Aarhus | 2018-06-30 |
| NCT02605512 | BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study | https://ClinicalTrials.gov/show/NCT02605512 | Recruiting | Institut de Radioprotection et de Surete Nucleaire | 2019-09-30 |
| NCT03389724 | Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia | https://ClinicalTrials.gov/show/NCT03389724 | Recruiting | Children’s Cancer Hospital Egypt 57357 | 2020-11-14 |
| NCT02471885 | Effect of Remote Ischaemic Conditioning in Oncology Patients | https://ClinicalTrials.gov/show/NCT02471885 | Recruiting | University College, London | 2020-12-31 |
| NCT02471053 | Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study | https://ClinicalTrials.gov/show/NCT02471053 | Completed | Nova Scotia Health Authority | 2017-09-30 |
| NCT02236806 | Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab | https://ClinicalTrials.gov/show/NCT02236806 | Recruiting | Azienda Ospedaliero-Universitaria Careggi | 2021-07-31 |
| NCT02177175 | Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification | https://ClinicalTrials.gov/show/NCT02177175 | Active, not recruiting | Memorial Sloan Kettering Cancer Center | 2021-06-30 |
| NCT02096588 | Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin | https://ClinicalTrials.gov/show/NCT02096588 | Active, not recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-04-25 |
| NCT02053974 | Spironolactone Against Anthracycline-induced Cardiomyopathy | https://ClinicalTrials.gov/show/NCT02053974 | Completed | TC Erciyes University | 2012-10-31 |
| NCT01968200 | Prevention of Anthracycline-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT01968200 | Active, not recruiting | European Institute of Oncology | 2019-12-31 |
| NCT01724450 | Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT01724450 | Completed | University of Sao Paulo | 2017-06-30 |
| NCT04429633 | Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer | https://ClinicalTrials.gov/show/NCT04429633 | Recruiting | Samsung Medical Center | 2022-07-18 |
| NCT04105634 | Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT | https://ClinicalTrials.gov/show/NCT04105634 | Active, not recruiting | University of Pennsylvania | 2021-10-01 |
| NCT04047901 | Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment | https://ClinicalTrials.gov/show/NCT04047901 | Recruiting | University of Sao Paulo General Hospital | 2021-02-28 |
| NCT04044872 | Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT04044872 | Recruiting | University of Texas Southwestern Medical Center | 2021-10-31 |
| NCT04030546 | Ivabradine to Prevent Anthracycline-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT04030546 | Recruiting | Vilnius University | 2020-06-01 |
| NCT04023110 | Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab | https://ClinicalTrials.gov/show/NCT04023110 | Recruiting | Abramson Cancer Center of the University of Pennsylvania | 2022-02-28 |
| NCT03964142 | Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT03964142 | Recruiting | Hospital Clinico Universitario de Santiago | 2020-08-01 |
| NCT03940625 | Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping | https://ClinicalTrials.gov/show/NCT03940625 | Recruiting | Heinrich-Heine University, Duesseldorf | 2022-12-31 |
| NCT03934905 | Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction | https://ClinicalTrials.gov/show/NCT03934905 | Recruiting | Texas Tech University Health Sciences Center | 2021-06-01 |
| NCT03850171 | Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study | https://ClinicalTrials.gov/show/NCT03850171 | Recruiting | University Hospital Inselspital, Berne | 2021-03-31 |
| NCT03711110 | Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) | https://ClinicalTrials.gov/show/NCT03711110 | Recruiting | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 2024-08-02 |
| NCT03645317 | Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent Radiotherapy | https://ClinicalTrials.gov/show/NCT03645317 | Recruiting | The Christie NHS Foundation Trust | 2020-04-01 |
| NCT03553654 | Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT03553654 | Recruiting | University of California, San Diego | 2021-01-09 |
| NCT03486340 | Prevention of Chest Pain in Chemo-treated Cancer Patients | https://ClinicalTrials.gov/show/NCT03486340 | Recruiting | Vejle Hospital | 2021-12-31 |
| NCT01230983 | Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin’s Lymphoma | https://ClinicalTrials.gov/show/NCT01230983 | Completed | Children’s Oncology Group | 2001-09-30 |
| NCT01032278 | Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) | https://ClinicalTrials.gov/show/NCT01032278 | Active, not recruiting | M.D. Anderson Cancer Center | 2020-01-31 |
| NCT01009918 | Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab | https://ClinicalTrials.gov/show/NCT01009918 | Completed | University of South Florida | 2017-08-31 |
| NCT00854568 | Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL | https://ClinicalTrials.gov/show/NCT00854568 | Completed | Fudan University | 2012-12-31 |
| NCT01719562 | MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum | https://ClinicalTrials.gov/show/NCT01719562 | Recruiting | Wake Forest University Health Sciences | 2021-05-31 |
| NCT03650205 | Ivabradine to Prevent Anthracycline-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT03650205 | Recruiting | University of Sao Paulo | 2021-10-01 |
| NCT00577798 | Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin | https://ClinicalTrials.gov/show/NCT00577798 | Completed | University of Nebraska | 2012-12-31 |
| NCT00575406 | Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma | https://ClinicalTrials.gov/show/NCT00575406 | Completed | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2012-01-31 |
| NCT00543062 | Staccato Prochlorperazine Thorough QT/QTc | https://ClinicalTrials.gov/show/NCT00543062 | Completed | Alexza Pharmaceuticals, Inc. | 2007-12-31 |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | https://ClinicalTrials.gov/show/NCT00530101 | Completed | University of Miami | 2008-03-31 |
| NCT00459771 | Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity | https://ClinicalTrials.gov/show/NCT00459771 | Completed | The Netherlands Cancer Institute | 2013-12-31 |
| NCT00436566 | Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery | https://ClinicalTrials.gov/show/NCT00436566 | Completed | Mayo Clinic | 2009-04-30 |
| NCT00292526 | Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients | https://ClinicalTrials.gov/show/NCT00292526 | Completed | European Institute of Oncology | 2011-11-30 |
| NCT00247975 | Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy | https://ClinicalTrials.gov/show/NCT00247975 | Completed | Ottawa Heart Institute Research Corporation | 2010-10-31 |
| NCT00162955 | Prevention of CHOP-induced Chronic Cardiotoxicity | https://ClinicalTrials.gov/show/NCT00162955 | Completed | Osaka City University | 2010-09-30 |
| NCT00005578 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin’s Disease | https://ClinicalTrials.gov/show/NCT00005578 | Completed | Children’s Oncology Group | 2004-10-31 |
| NCT00002827 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin’s Disease | https://ClinicalTrials.gov/show/NCT00002827 | Completed | Children’s Oncology Group | 2004-10-31 |
| NCT00003070 | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | https://ClinicalTrials.gov/show/NCT00003070 | Completed | Children’s Oncology Group | 2003-07-31 |
| NCT00039481 | Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | https://ClinicalTrials.gov/show/NCT00039481 | Completed | National Cancer Institute (NCI) | 2005-10-31 |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | https://ClinicalTrials.gov/show/NCT00003937 | Completed | Children’s Oncology Group | 2004-03-31 |
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT02615054 | Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors | https://ClinicalTrials.gov/show/NCT02615054 | Active, not recruiting | Memorial Sloan Kettering Cancer Center | 2020-11-30 |
| NCT03301389 | Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest) | https://ClinicalTrials.gov/show/NCT03301389 | Recruiting | Yonsei University | 2025-01-31 |
| NCT03259711 | Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase | https://ClinicalTrials.gov/show/NCT03259711 | Completed | Groupe Hospitalier Pitie-Salpetriere | 2017-08-14 |
| NCT03243604 | cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study | https://ClinicalTrials.gov/show/NCT03243604 | Completed | Groupe Hospitalier Pitie-Salpetriere | 2017-07-13 |
| NCT03235427 | The CAROLE (CArdiac Related Oncologic Late Effects) Study | https://ClinicalTrials.gov/show/NCT03235427 | Completed | Northwell Health | 2018-06-26 |
| NCT03193138 | CardioTOxicity Induced by andRogeNICS and Their Antagonists (TORNICS) | https://ClinicalTrials.gov/show/NCT03193138 | Completed | Groupe Hospitalier Pitie-Salpetriere | 2017-06-21 |
| NCT03155802 | Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines | https://ClinicalTrials.gov/show/NCT03155802 | Recruiting | Stony Brook University | 2020-12-31 |
| NCT02916316 | Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell | https://ClinicalTrials.gov/show/NCT02916316 | Recruiting | Fondazione Italiana Linfomi ONLUS | 2020-12-31 |
| NCT02875171 | Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT02875171 | Completed | Versailles Hospital | 2015-05-31 |
| NCT02798679 | Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity | https://ClinicalTrials.gov/show/NCT02798679 | Recruiting | University of Minnesota | 2020-12-31 |
| NCT02769299 | Cardiotoxicity of Radiation Therapy (CTRT) | https://ClinicalTrials.gov/show/NCT02769299 | Completed | Abramson Cancer Center of the University of Pennsylvania | 2018-11-26 |
| NCT02440620 | Cardiac Toxicity in Medical Treatment of Breast Cancer | https://ClinicalTrials.gov/show/NCT02440620 | Completed | Odense University Hospital | 2018-08-31 |
| NCT02423356 | Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin | https://ClinicalTrials.gov/show/NCT02423356 | Completed | Indiana University | 2018-02-01 |
| NCT02306538 | Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI | https://ClinicalTrials.gov/show/NCT02306538 | Recruiting | University Health Network, Toronto | 2020-10-31 |
| NCT02274480 | Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT02274480 | Active, not recruiting | Memorial Sloan Kettering Cancer Center | 2020-10-31 |
| NCT02086695 | Early Detection of Broken Hearts in Cancer Patients | https://ClinicalTrials.gov/show/NCT02086695 | Completed | Mayo Clinic | 2015-09-30 |
| NCT02065908 | Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer | https://ClinicalTrials.gov/show/NCT02065908 | Completed | West Pomeranian Cancer Center | 2016-06-30 |
| NCT01805778 | Preventing Cardiac Sequelae in Pediatric Cancer Survivors | https://ClinicalTrials.gov/show/NCT01805778 | Completed | The Hospital for Sick Children | 2018-09-30 |
| NCT01671696 | Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy | https://ClinicalTrials.gov/show/NCT01671696 | Recruiting | Connecticut Children’s Medical Center | 2020-05-31 |
| NCT01665300 | Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT01665300 | Completed | Seoul National University Hospital | 2013-12-31 |
| NCT01572883 | Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer | https://ClinicalTrials.gov/show/NCT01572883 | Completed | Institute of Oncology Ljubljana | 2012-07-31 |
| NCT04409379 | Association Between Telomere Length and Cardiac Dysfunction | https://ClinicalTrials.gov/show/NCT04409379 | Completed | Fourth Military Medical University | 2020-05-01 |
| NCT04262830 | Cancer Therapy Effects on the Heart | https://ClinicalTrials.gov/show/NCT04262830 | Recruiting | University of California, San Diego | 2021-09-30 |
| NCT04191265 | Cardiotoxicity of Aluminum Phosphide Poisoning; Tropinin and CKmb as Early Biomarkers | https://ClinicalTrials.gov/show/NCT04191265 | Active, not recruiting | Assiut University | 2020-06-05 |
| NCT04055636 | Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy. | https://ClinicalTrials.gov/show/NCT04055636 | Recruiting | Moscow State University of Medicine and Dentistry | 2021-06-30 |
| NCT04046315 | Early Detection of Cardiac Damage With CMR in Women With Breast Cancer | https://ClinicalTrials.gov/show/NCT04046315 | Recruiting | Radboud University | 2021-03-31 |
| NCT04036032 | Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy | https://ClinicalTrials.gov/show/NCT04036032 | Recruiting | Connecticut Children’s Medical Center | 2021-06-30 |
| NCT03930394 | Vascular Cardiotoxicity of Ponatinib | https://ClinicalTrials.gov/show/NCT03930394 | Recruiting | Oregon Health and Science University | 2021-05-01 |
| NCT03882580 | Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care | https://ClinicalTrials.gov/show/NCT03882580 | Recruiting | Groupe Hospitalier Pitie-Salpetriere | 2025-03-01 |
| NCT03543228 | MyoStrain CMR for the Detection of Cardiotoxicity | https://ClinicalTrials.gov/show/NCT03543228 | Active, not recruiting | Myocardial Solutions | 2018-12-31 |
| NCT03480087 | Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma | https://ClinicalTrials.gov/show/NCT03480087 | Recruiting | Azienda Ospedaliera Città della Salute e della Scienza di Torino | 2020-07-31 |
| NCT01246778 | Sunitinib and Atrial Trabeculae Contractility | https://ClinicalTrials.gov/show/NCT01246778 | Completed | Radboud University | 2014-04-30 |
| NCT01173341 | Cardiotoxicity of Cancer Therapy (CCT) | https://ClinicalTrials.gov/show/NCT01173341 | Active, not recruiting | Abramson Cancer Center of the University of Pennsylvania | 2029-04-30 |
| NCT01014065 | A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) | https://ClinicalTrials.gov/show/NCT01014065 | Completed | AHS Cancer Control Alberta | 2012-11-30 |
| NCT00968682 | CADY Study ICORG 08-01 | https://ClinicalTrials.gov/show/NCT00968682 | Completed | Cancer Trials Ireland | 2014-04-30 |
| NCT00875238 | Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab | https://ClinicalTrials.gov/show/NCT00875238 | Completed | Vanderbilt University Medical Center | 2015-03-31 |
| NCT00858039 | Cardiotoxicity of Adjuvant Trastuzumab | https://ClinicalTrials.gov/show/NCT00858039 | Completed | Royal Prince Alfred Hospital, Sydney, Australia | 2013-07-31 |
| NCT04260269 | Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study | https://ClinicalTrials.gov/show/NCT04260269 | Enrolling by invitation | Helsinki University Central Hospital | 2020-12-31 |
| NCT00806507 | Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients | https://ClinicalTrials.gov/show/NCT00806507 | Completed | M.D. Anderson Cancer Center | 2011-08-31 |
| NCT00636844 | Detection of Chemotherapy Induced Cardiotoxicity | https://ClinicalTrials.gov/show/NCT00636844 | Completed | George Washington University | 2011-12-31 |
| NCT00002900 | SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial | https://ClinicalTrials.gov/show/NCT00002900 | Completed | Southwest Oncology Group | 2008-03-31 |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04461223 | Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR | https://ClinicalTrials.gov/show/NCT04461223 | Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | 2021-12-01 |
| NCT02818517 | Evaluation and Management of Cardio Toxicity in Oncologic Patients | https://ClinicalTrials.gov/show/NCT02818517 | Recruiting | Tel-Aviv Sourasky Medical Center | 2030-11-30 |
| NCT04026737 | Cardiovascular Effects of CART Cell Therapy | https://ClinicalTrials.gov/show/NCT04026737 | Recruiting | Abramson Cancer Center of the University of Pennsylvania | 2021-07-31 |
| NCT03981588 | Cardiotoxicity in the Elderly | https://ClinicalTrials.gov/show/NCT03981588 | Active, not recruiting | AORTICA Group | 2016-12-31 |
| NCT03760237 | Cardiovascular Function in Acute Leukemia | https://ClinicalTrials.gov/show/NCT03760237 | Enrolling by invitation | Abramson Cancer Center of the University of Pennsylvania | 2021-12-31 |